AFMD (Affimed NV) FCF Yield % : -239.32 (As of Dec. 15, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Affimed NV FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Affimed NV's Trailing 12-Month Free Cash Flow is $-84.35 Mil, and Market Cap is $35.24 Mil. Therefore, Affimed NV's FCF Yield % for today is -239.32%.

The historical rank and industry rank for Affimed NV's FCF Yield % or its related term are showing as below:

AFMD' s FCF Yield % Range Over the Past 10 Years
Min: -269.8 Med: -23.35 Max: 34.32
Current: -239.32

During the past 12 years, the highest FCF Yield % of Affimed NV was 34.32%. The lowest was -269.80%. And the median was -23.35%.

AFMD's FCF Yield % is ranked worse than
93.17% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs AFMD: -239.32

Affimed NV's FCF Margin % for the quarter that ended in Sep. 2024 was -7,188.37%.

Affimed NV FCF Yield % Historical Data

The historical data trend for Affimed NV's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affimed NV FCF Yield % Chart

Affimed NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-16.24

-4.22

-15.00

-60.40

-132.62

Affimed NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial															-128.37	-120.76	-128.32	-83.27	-89.79

Competitive Comparison of Affimed NV's FCF Yield %

For the Biotechnology subindustry, Affimed NV's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Affimed NV's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affimed NV's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Affimed NV's FCF Yield % falls into.

Affimed NV FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Affimed NV's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-124.317	/	93.7425
	=	-132.62%

Affimed NV's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-12.364	*	4	/	55.078128
	=	-89.79%

Affimed NV FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Affimed NV FCF Yield % Related Terms

Thank you for viewing the detailed overview of Affimed NV's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Affimed NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (NAS:AFMD) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

0HL9:UK A28A:Germany

Address

Gottlieb-Daimler-Strabe 2, Mannheim, BW, DEU, 68165

Website

https://www.affimed.com

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.